美国 FDA · 官方机构
6月26日 12:00 · 阅读约 1 分钟
美国 FDA· US精选85分
Medical Devices; Clinical Chemistry and Toxicology Devices; Classification of the Prognostic Test for Development or Progression of Preeclampsia
摘要
The Food and Drug Administration (FDA) is classifying the prognostic test for development or progression of preeclampsia into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the prognostic test for development or progression of preeclampsia. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of
五维评分
信源权威度
95
影响范围
90
合规紧急度
75
行业关注度
90
时效性
50